0
0
New Delhi, December 18 — The indigenously developed quadrivalent Human Papillomavirus (HPV) vaccine, CERVAVAC, has emerged as a game-changer in India’s battle against cervical cancer, said Union Minister of State for Science and Technology, Jitendra Singh. Speaking at the NDTV Health Conclave held at Hotel Hyatt, Singh highlighted the vaccine’s affordability and superior efficacy in preventing cervical cancer.
Cervical cancer is the second most prevalent cancer among women in India and accounts for nearly one-fourth of the world’s cervical cancer deaths, despite being largely preventable. Annually, around 100,000 women in India succumb to the disease, with over 90% of cases linked to HPV infections.
“The quadrivalent HPV vaccine is a boon for the Indian population, especially given the high mortality rate among women due to cervical cancer,” Singh said. He noted that the vaccine’s affordability makes it accessible to a broader section of the population, a critical factor in addressing the health challenge.
A Major Milestone in Vaccine Development
Singh also reiterated the significance of CERVAVAC, India’s first indigenously developed HPV vaccine, launched in September 2022 by the Department of Biotechnology under the Ministry of Science and Technology. The vaccine targets four HPV strains—6, 11, 16, and 18—most closely associated with cervical cancer in women.
“CERVAVAC’s quadrivalent nature makes it highly effective and unique, marking a significant milestone in India’s healthcare innovations,” Singh stated. He emphasized its simple administration: a two-dose regimen for girls under 15 years and a three-dose regimen for older age groups.
Advancing Preventive Healthcare
The conclave, themed “Together Against HPV,” underscored India’s advancements in preventive healthcare, particularly in addressing women’s health. Singh highlighted the global recognition India has received for its preventive healthcare initiatives, attributing it to the country’s focus on indigenous vaccine development and public health campaigns.
He stressed the importance of eradicating taboos and stigma surrounding diseases like cervical cancer, especially in rural and underprivileged areas. “Addressing social stigma is crucial to ensuring early diagnosis and treatment,” he said.
Vision for 2047: Women-Led Development
Prioritizing women’s health is integral to India’s vision for 2047, Singh asserted, aligning with the government’s focus on women-led development. He called for collaborative efforts from policymakers, healthcare professionals, and community leaders to bolster cervical cancer prevention and treatment.
The conclave also featured discussions on awareness campaigns, vaccine delivery mechanisms, and the role of public-private partnerships in expanding vaccine coverage nationwide.
As India strengthens its fight against cervical cancer, the launch of CERVAVAC represents a critical step forward, promising a healthier future for women and underscoring the nation’s leadership in preventive healthcare.
